title: Developments in the immunophenotypic analysis of haematological malignancies.
abstract: Immunophenotyping is the method by which antibodies are used to detect cellular antigens in clinical samples. Although the major role is in the diagnosis and classification of haematological malignancies, applications have expanded over the past decade. Immunophenotyping is now used extensively for disease staging and monitoring, to detect surrogate markers of genetic aberrations, to identify potential immuno-therapeutic targets and to aid prognostic prediction. This expansion in applications has resulted from developments in antibodies, methodology, automation and data handling. In this review we describe recent advances in both the technology and applications for the analysis of haematological malignancies. We highlight the importance of the expanding repertoire of testing capability for diagnostic, prognostic and therapeutic applications. The impact and significance of immunophenotyping in the assessment of haematological neoplasms are evident.
authors.affiliation: Pathology and Laboratory Medicine, University of Western Australia, Crawley, WA 6009, Australia. kathy.heel@uwa.edu.au
authors.forename: Kathy
authors.initials: K
authors.lastname: Heel
authors.forename: Tania
authors.initials: T
authors.lastname: Tabone
authors.forename: Kimberley J
authors.initials: KJ
authors.lastname: Röhrig
authors.forename: Phillip G
authors.initials: PG
authors.lastname: Maslen
authors.forename: Katie
authors.initials: K
authors.lastname: Meehan
authors.forename: Lizz F
authors.initials: LF
authors.lastname: Grimwade
authors.forename: Wendy N
authors.initials: WN
authors.lastname: Erber
mesh_terms: D019337:Hematologic Neoplasms / Q000175:diagnosis / Q000276:immunology*; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping / Q000379:methods*
keywords: Bone marrow; Flow cytometry; Immunocytochemistry; Immunophenotyping